Keywords
MENA
Egypt
Stigma and discrimination
HIV epidemiology
Categories
How to Cite
Abstract
Introduction: Human immunodeficiency virus (HIV) continues to represent one of the most significant public health challenges, with Egypt facing a rapidly and silently growing epidemic masked by its low-prevalence classification. This narrative review tracks the historical trajectory of HIV in Egypt, from its silent beginning in 1986 to its current status. It aims to provide critical insight into how more effective and equitable interventions and policies can be framed to address this public health challenge.
Methods: We synthesized data from a non-systematic search including national and international reports, estimates, surveys, and peer-reviewed papers addressing epidemiology, trends, social determinants, and health-system performance related to Egypt. Literature was identified through PubMed, Google Scholar, and reports from UNAIDS, WHO, and the Egyptian Ministry of Health. We prioritized literature published on data specific to Egypt. Where local data were unavailable, regional and global data were used to provide context and identify research gaps.
Results: The review revealed Egypt’s transition to a concentrated epidemic. It identified significant gaps in local research and long-term health outcomes and showed that, despite National AIDS Program efforts, the availability of free antiretroviral therapy, and the adoption of a “Treat All” policy, gaps persist.
Conclusion: The 40-year story of HIV in Egypt revealed rising incidence, critical gaps in the treatment cascade, and a lack of local data on non-infectious comorbidities. Addressing these challenges, promoting early diagnosis, reducing stigma, expanding access to treatment, and adopting innovative prevention strategies are essential to reverse current trends.
References
1. Sah AK, Elshaikh RH, Shalabi MG, Abbas AM, Prabhakar PK, Babker AMA, Choudhary RK, Gaur V, Choudhary AS, Agarwal S. Role of Artificial Intelligence and Personalized Medicine in Enhancing HIV Management and Treatment Outcomes. Life (Basel). 2025: 745 [PMID: 40430173, https://doi.org/10.3390/life15050745]
2. Beyrer C. A pandemic anniversary: 40 years of HIV/AIDS. Lancet. 2021: 2142 [PMID: 34087110, https://doi.org/10.1016/S0140-6736(21)01167-3]
3. Immaculata Ugwu N, Nwachi Ugwu C, Ariel Onoka C, Ehigiator Iyare F, Friday Una A, Marchand C. Knowledge, Perception And Practice Of Preventive Lifestyle Against HIV/AIDS Among Students Of A Tertiary Educational Institution In South Eastern Nigeria. Journal of Clinical Research In HIV AIDS And Prevention. 2015: 29 https://doi.org/10.14302/issn.2324-7339.jcrhap-15-648]
4. UNAIDS. Fact sheet - Latest global and regional statistics on the status of the AIDS epidemic2025:
5. Magdy M, Zaki A, Osman SO, Abd El-Wahab EW, Abd Elhameed A. Stigma among people living with HIV in Northern Egypt. openRxiv. 2024: https://doi.org/10.1101/2024.08.27.24312679]
6. Khalil A, Shaltout M, Costa S. Identifying Opportunity for Online Education to Address HIV/HCV Knowledge Gaps in Health Professionals and Students in Egypt. Ann Glob Health. 2018: 580 [PMID: 30779503, https://doi.org/10.9204/aogh.2388]
7. Boutros S, Skordis J. HIV/AIDS surveillance in Egypt: current status and future challenges. East Mediterr Health J. 2010: 251 [PMID: 20795437, https://doi.org/10.26719/2010.16.3.251]
8. Al-Abri S, Mokhbat JE. HIV in the MENA Region: Cultural and Political Challenges. Int J Infect Dis. 2016: 64 [PMID: 26873278, https://doi.org/10.1016/j.ijid.2016.01.017]
9. Ghazy RM, Al Awaidy S, Taha SHN. Trends of HIV indicators in Egypt from 1990 to 2021: time-series analysis and forecast toward UNAIDS 90-90-90 targets. BMC Public Health. 2023: 625 [PMID: 37005670, https://doi.org/10.1186/s12889-023-15490-5]
10. Holmes KK, Bertozzi S, Bloom BR, Jha P. Disease Control Priorities, Third Edition (Volume 6): Major Infectious Diseases. Washington, DC: World Bank. 2017: https://doi.org/10.1596/978-1-4648-0524-0]
11. UNAIDS. Egypt | UNAIDS [Accessed 2025-12-25]. Joint United Nations Programme on HIV/AIDS (UNAIDS); 2025 [updated 2025-12-25]. Available from: https://www.unaids.org/en/regionscountries/countries/egypt.
12. UNAIDS. UNAIDS2017:
13. El-Gibaly O, Eskander DA, Amin MT. Trends in newly diagnosed HIV cases at Assiut university hospital, Egypt. Discover Public Health. 2025: https://doi.org/10.1186/s12982-025-00525-6]
14. Khorrami Z, Balooch Hasankhani M, Khezri M, Jafari-Khounigh A, Jahani Y, Sharifi H. Trends and projection of incidence, mortality, and disability-adjusted life years of HIV in the Middle East and North Africa (1990-2030). Sci Rep. 2023: 13859 [PMID: 37620356, https://doi.org/10.1038/s41598-023-40743-z]
15. UNAIDS. UNAIDS Global AIDS Update 2023: United Nations; 2023.
16. Sheba MF, Woody JN, Zaki AM, Morrill JC, Burans J, Farag I, Kashaba S, Madkour S, Mansour M. The prevalence of HIV infection in Egypt. Trans R Soc Trop Med Hyg. 1988: 634 [PMID: 3256121, https://doi.org/10.1016/0035-9203(88)90540-8]
17. Shawky S, Soliman C, Kassak KM, Oraby D, El-Khoury D, Kabore I. HIV surveillance and epidemic profile in the Middle East and North Africa. J Acquir Immune Defic Syndr. 2009: S83 [PMID: 19553783, https://doi.org/10.1097/QAI.0b013e3181aafd3f]
18. Kabbash IA, El-Gueneidy M, Sharaf AY, Hassan NM, Al-Nawawy N. Needs assessment and coping strategies of persons infected with HIV in Egypt. East Mediterr Health J. 2008: 1308 [PMID: 19161106,
19. Anwar S, El Kharrat E, Bakhoum A, El-Sadr WM, Harris TG. Association of sociodemographic factors with needle sharing and number of sex partners among people who inject drugs in Egypt. Glob Public Health. 2022: 1689 [PMID: 34283695, https://doi.org/10.1080/17441692.2021.1950798]
20. El-Sayyed N, Kabbash IA, El-Gueniedy M. Risk behaviours for HIV/AIDS infection among men who have sex with men in Cairo, Egypt. East Mediterr Health J. 2008: 905 [PMID: 19166174,
21. Egypt National HIV Strategic Plan 2021-2025. Accessed 2025-12-25. UNAIDS HIV Prevention Coalition, 2021.
22. Aziz MM, Abdelrheem SS, Mohammed HM. Stigma and discrimination against people living with HIV by health care providers in Egypt. BMC Health Serv Res. 2023: 663 [PMID: 37340396, https://doi.org/10.1186/s12913-023-09676-1]
23. Mohamed R, Wanis H, Zebachi S, El-Kotamy MT, Esmat G, Cordie A. COVID-19 crisis effect on HIV service delivery in Egypt: Hard times or blessings in disguise? South Afr J HIV Med. 2020: 1170 [PMID: 33354367, https://doi.org/10.4102/sajhivmed.v21i1.1170]
24. Ferreyra C, O'Brien D, Alonso B, Al-Zomour A, Ford N. Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen. Confl Health. 2018: 30 [PMID: 29988565, https://doi.org/10.1186/s13031-018-0161-1]
25. Badahdah AM, Pedersen DE. "I want to stand on my own legs": A qualitative study of antiretroviral therapy adherence among HIV-positive women in Egypt. AIDS Care. 2011: 700 [PMID: 21476148, https://doi.org/10.1080/09540121.2010.534431]
26. WHO. Pre-exposure prophylaxis (PrEP) 2025. Available from: https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/prevention/pre-exposure-prophylaxis.
27. Egypt 2025. Available from: http://open.unaids.org/countries/egypt.
28. Okasha H, Afifi AR, Ibrahim KI-E, Emad R, Alzahaby AA, Abdel-Baki A, Goumaa R, Amer AF. Human immunodeficiency virus pretreatment drug resistance to first line antiretroviral therapy: a single center study. The Egyptian Journal of Internal Medicine. 2025: https://doi.org/10.1186/s43162-025-00441-w]
29. Bio-BSS. Bio-BSS summary report 2006 final web site.doc 2006. Available from: https://www.fhi360.org/wp-content/uploads/2024/02/EgyptBioBSSsummaryreport2006.pdf.
30. Bio-BSS. Bio-BSS summary report 2010 2010. Available from: https://www.fhi360.org/wp-content/uploads/drupal/documents/BBSS%202010_0.pdf.
31. Lembas A, Zaleski A, Peller M, Mikula T, Wiercinska-Drapalo A. Human Immunodeficiency Virus as a Risk Factor for Cardiovascular Disease. Cardiovasc Toxicol. 2024: 1 [PMID: 37982976, https://doi.org/10.1007/s12012-023-09815-4]
32. Chu C, Pollock LC, Selwyn PA. HIV-Associated Complications: A Systems-Based Approach. Am Fam Physician. 2017: 161 [PMID: 28762691,
33. Webel AR, Schexnayder J, Cioe PA, Zuniga JA. A Review of Chronic Comorbidities in Adults Living With HIV: State of the Science. J Assoc Nurses AIDS Care. 2021: 322 [PMID: 33595986, https://doi.org/10.1097/JNC.0000000000000240]
34. Zhabokritsky A, Klein M, Loutfy M, Guaraldi G, Andany N, Guillemi S, Falutz J, Arbess G, Tan DHS, Walmsley S. Non-AIDS-defining comorbidities impact health related quality of life among older adults living with HIV. Front Med (Lausanne). 2024: 1380731 [PMID: 38690177, https://doi.org/10.3389/fmed.2024.1380731]
35. Abdelgawad O, El-Bendary M, Elegezy M, Abdel-Razik A, Farid K, El-Gilany A-H, El-Eraky A. Coinfection of Hepatitis C Virus with Human Immunodeficiency Virus: Not the End of the Story: A Multicenter Egyptian Study. Afro-Egyptian Journal of Infectious and Endemic Diseases. 2023: 114 https://doi.org/10.21608/aeji.2023.205584.1285]
36. Elrashdy F, Hagag S, Mohamed R, Abdel Alem S, Meshaal S, Cordie A, Elsharkawy A, Esmat G. Incidence of hepatitis C virus infection among people living with HIV: An Egyptian cohort study. South Afr J HIV Med. 2022: 1442 [PMID: 36479422, https://doi.org/10.4102/sajhivmed.v23i1.1442]
37. Mohamed IELK, El-Saeed KM, Al-Sadik MH, Anwar CA. Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients. Egyptian Liver Journal. 2021: https://doi.org/10.1186/s43066-021-00089-5]
38. Eletreby R, Esmat G, Elsharkawy A, Alsehemy L, Mohamed R, Alem SA, Yousof H, Cordie A, Lithy RM. HCV/HIV coinfected Egyptian patients: a cross-sectional study of their main characteristics and barriers to HCV treatment initiation. Trans R Soc Trop Med Hyg. 2022: 227 [PMID: 34291286, https://doi.org/10.1093/trstmh/trab106]
39. Lekoane KMB, Kuupiel D, Mashamba-Thompson TP, Ginindza TG. The interplay of HIV and human papillomavirus-related cancers in sub-Saharan Africa: scoping review. Syst Rev. 2020: 88 [PMID: 32321580, https://doi.org/10.1186/s13643-020-01354-1]
40. Perez-Gonzalez A, Cachay E, Ocampo A, Poveda E. Update on the Epidemiological Features and Clinical Implications of Human Papillomavirus Infection (HPV) and Human Immunodeficiency Virus (HIV) Coinfection. Microorganisms. 2022: 1047 [PMID: 35630489, https://doi.org/10.3390/microorganisms10051047]
41. Tadese BK, You X, Ndao T, Tota JE, Chen YT, Chowdhary A, Pan J, Costa AC, Mugo N. The Burden of HPV Infections and HPV-Related Diseases Among People With HIV: A Systematic Literature Review. J Med Virol. 2025: e70274 [PMID: 40172095, https://doi.org/10.1002/jmv.70274]
42. Stelzle D, Tanaka LF, Lee KK, Ibrahim Khalil A, Baussano I, Shah ASV, McAllister DA, Gottlieb SL, Klug SJ, Winkler AS, Bray F, Baggaley R, Clifford GM, Broutet N, Dalal S. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021: e161 [PMID: 33212031, https://doi.org/10.1016/S2214-109X(20)30459-9]
43. Ashry M, Shawky S, Mounir Z, Fathy F, Elsayed H, Kamal W, Hassany M. Prevalence and risk factors of human papilloma virus infection among women living with HIV, Egypt, a cross sectional study. BMC Public Health. 2024: 1821 [PMID: 38978047, https://doi.org/10.1186/s12889-024-19240-z]
44. Zaki ZM, Khalil MM, Wagih KM, Ezzelregal HG. HIV-related pulmonary manifestations among Egyptian patients. The Egyptian Journal of Chest Diseases and Tuberculosis. 2023: 120 https://doi.org/10.4103/ecdt.ecdt_45_22]
45. Belew H, Wubie M, Tizazu G, Bitew A, Birlew T. Predictors of tuberculosis infection among adults visiting anti-retroviral treatment center at east and west Gojjam, northwest, Ethiopia, 2017. BMC Infect Dis. 2020: 593 [PMID: 32787798, https://doi.org/10.1186/s12879-020-05290-2]
46. Manosuthi W, Charoenpong L, Santiwarangkana C. A retrospective study of survival and risk factors for mortality among people living with HIV who received antiretroviral treatment in a resource-limited setting. AIDS Res Ther. 2021: 71 [PMID: 34641922, https://doi.org/10.1186/s12981-021-00397-1]
47. Zhang SX, Wang JC, Yang J, Lv S, Duan L, Lu Y, Tian LG, Chen MX, Liu Q, Wei FN, Feng XY, Yang GB, Li YJ, Wang Y, Hu XJ, Yang M, Lu ZH, Zhang SY, Li SZ, Zheng JX. Epidemiological features and temporal trends of the co-infection between HIV and tuberculosis, 1990-2021: findings from the Global Burden of Disease Study 2021. Infect Dis Poverty. 2024: 59 [PMID: 39152514, https://doi.org/10.1186/s40249-024-01230-3]
48. Amin W, Ashmawy R, Ibrahim SA, El-Maradny YA, Elsawy NH, Gebili SA, Gamaleldin N, Ghazy RM. Incidence and determinants of extrapulmonary tuberculosis in Egypt: a retrospective cohort study. Sci Rep. 2025: 13631 [PMID: 40254648, https://doi.org/10.1038/s41598-025-95699-z]
49. Pathmanathan I, Ahmedov S, Pevzner E, Anyalechi G, Modi S, Kirking H, Cavanaugh JS. TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings. Int J Tuberc Lung Dis. 2018: 596 [PMID: 29862942, https://doi.org/10.5588/ijtld.17.0758]
50. Bonnet F, Le Marec F, Leleux O, Gerard Y, Neau D, Lazaro E, Duffau P, Caubet O, Vandenhende MA, Mercie P, Cazanave C, Dabis F. Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort. BMC Infect Dis. 2020: 850 [PMID: 33198667, https://doi.org/10.1186/s12879-020-05593-4]
51. Fontela C, Aguinaga A, Moreno-Iribas C, Reparaz J, Rivero M, Gracia M, Floristan Y, Fresan U, Miguel RS, Ezpeleta C, Castilla J. Trends and causes of mortality in a population-based cohort of HIV-infected adults in Spain: comparison with the general population. Sci Rep. 2020: 8922 [PMID: 32488053, https://doi.org/10.1038/s41598-020-65841-0]
52. Trickey A, McGinnis K, Gill MJ, Abgrall S, Berenguer J, Wyen C, Hessamfar M, Reiss P, Kusejko K, Silverberg MJ, Imaz A, Teira R, d'Arminio Monforte A, Zangerle R, Guest JL, Papastamopoulos V, Crane H, Sterling TR, Grabar S, Ingle SM, Sterne JAC. Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies. Lancet HIV. 2024: e176 [PMID: 38280393, https://doi.org/10.1016/S2352-3018(23)00272-2]
53. Bosh KA, Johnson AS, Hernandez AL, Prejean J, Taylor J, Wingard R, Valleroy LA, Hall HI. Vital Signs: Deaths Among Persons with Diagnosed HIV Infection, United States, 2010-2018. MMWR Morb Mortal Wkly Rep. 2020: 1717 [PMID: 33211683, https://doi.org/10.15585/mmwr.mm6946a1]
54. Verheij E, Boyd A, Wit F, Verboeket SO, Verburgh ML, van der Valk M, Schim van der Loeff MF, Reiss P, Study AC. Long-Term Trends in Comorbidity Evolution and Disease Burden in HIV-Positive Compared to HIV-Negative Individuals as They Age. SSRN Electronic Journal. 2022: https://doi.org/10.2139/ssrn.4057117]
55. Osei-Yeboah R, Tamuhla T, Ngwenya O, Tiffin N. Accessing HIV care may lead to earlier ascertainment of comorbidities in health care clients in Khayelitsha, Cape Town. PLOS Glob Public Health. 2021: e0000031 [PMID: 36962101, https://doi.org/10.1371/journal.pgph.0000031]
56. Maggi P, De Socio GV, Menzaghi B, Molteni C, Squillace N, Taramasso L, Guastavigna M, Gamboni G, Madeddu G, Vichi F, Cascio A, Sarchi E, Pellicano G, Martinelli CV, Celesia BM, Valsecchi L, Gulminetti R, Cenderello G, Parisini A, Calza L, Falasca K, Orofino G, Ricci E, Di Biagio A, Bonfanti P. Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity? BMC Infect Dis. 2022: 745 [PMID: 36151508, https://doi.org/10.1186/s12879-022-07739-y]
57. Henning RJ, Greene JN. The epidemiology, mechanisms, diagnosis and treatment of cardiovascular disease in adult patients with HIV. Am J Cardiovasc Dis. 2023: 101 [PMID: 37213313,
58. Benti DG, Daba DD, Hunegna G, Abdena D, Etefa A, Adugna M. 2024: https://doi.org/10.21203/rs.3.rs-5342438/v1]
59. Khalfallah M, Habib M, Kishk AM, Saeed B, Hemdan S, Eissa A, Aboomar AA, Hagag RY, Elnagar B. Atherosclerotic Cardiovascular Diseases in Middle Delta of Egypt: A Systematic Analysis of Risk Factors Associated with the Rising Burden of the Disease. Glob Heart. 2025: 11 [PMID: 39925839, https://doi.org/10.5334/gh.1395]
60. Nazari I, Feinstein MJ. Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management. Clin Microbiol Rev. 2024: e0009822 [PMID: 38299802, https://doi.org/10.1128/cmr.00098-22]
61. Cornejo-Juarez P, Cavildo-Jeronimo D, Volkow-Fernandez P. Non-AIDS defining cancer (NADC) among HIV-infected patients at an oncology tertiary-care center in Mexico. AIDS Res Ther. 2018: 16 [PMID: 30368240, https://doi.org/10.1186/s12981-018-0202-2]
62. Yarchoan R, Uldrick TS. HIV-Associated Cancers and Related Diseases. N Engl J Med. 2018: 1029 [PMID: 29539283, https://doi.org/10.1056/NEJMra1615896]
63. Chang HH. Weight Gain and Metabolic Syndrome in Human Immunodeficiency Virus Patients. Infect Chemother. 2022: 220 [PMID: 35706080, https://doi.org/10.3947/ic.2022.0061]
64. Trachunthong D, Tipayamongkholgul M, Chumseng S, Darasawang W, Bundhamcharoen K. Burden of metabolic syndrome in the global adult HIV-infected population: a systematic review and meta-analysis. BMC Public Health. 2024: 2657 [PMID: 39342258, https://doi.org/10.1186/s12889-024-20118-3]
65. Husain NE, Noor SK, Elmadhoun WM, Almobarak AO, Awadalla H, Woodward CL, Mital D, Ahmed MH. Diabetes, metabolic syndrome and dyslipidemia in people living with HIV in Africa: re-emerging challenges not to be forgotten. HIV AIDS (Auckl). 2017: 193 [PMID: 29184449, https://doi.org/10.2147/HIV.S137974]
66. Chihota BV, Mandiriri A, Shamu T, Muula G, Nyamutowa H, Taderera C, Mwamba D, Chilengi R, Bolton-Moore C, Bosomprah S, Egger M, Chimbetete C, Wandeler G, for Ie DEASA. Metabolic syndrome among treatment-naive people living with and without HIV in Zambia and Zimbabwe: a cross-sectional analysis. J Int AIDS Soc. 2022: e26047 [PMID: 36522287, https://doi.org/10.1002/jia2.26047]
67. Asgedom YS, Kebede TM, Gebrekidan AY, Koyira MM, Azeze GA, Lombebo AA, Efa AG, Haile KE, Kassie GA. Prevalence of metabolic syndrome among people living with human immunodeficiency virus in sub-Saharan Africa: a systematic review and meta-analysis. Sci Rep. 2024: 11709 [PMID: 38777850, https://doi.org/10.1038/s41598-024-62497-y]
68. Delpino MV, Quarleri J. Influence of HIV Infection and Antiretroviral Therapy on Bone Homeostasis. Front Endocrinol (Lausanne). 2020: 502 [PMID: 32982960, https://doi.org/10.3389/fendo.2020.00502]
69. Afraie M, Zamani K, Moradi G, Khateri S, Nikbakht N, Moradi Y. Osteoporosis and fracture risk among individuals with HIV: a systematic review and meta-analysis. Discover Public Health. 2025: https://doi.org/10.1186/s12982-025-00608-4]
70. Cummins NW. Metabolic Complications of Chronic HIV Infection: A Narrative Review. Pathogens. 2022: 197 [PMID: 35215140, https://doi.org/10.3390/pathogens11020197]
71. Yussuf FM, Barbarawi A, Nor MA, Ali AI, Sheikh IM, Ogedegbe OJ, Tabowei G, Jimoh A, Ozokolie GE, Igbinomwanhia O. A Systematic Review Exploring the Range of Renal Complications of Human Immunodeficiency Virus. Cureus. 2023: e36755 [PMID: 37123789, https://doi.org/10.7759/cureus.36755]
72. Asmelash D, Nigatie M. Chronic kidney disease and its associated factors in HIV-infected individuals: a comparison of antiretroviral therapy naive and experienced patients. Front Med (Lausanne). 2024: 1455688 [PMID: 39588184, https://doi.org/10.3389/fmed.2024.1455688]
73. Abraham AG, Althoff KN, Jing Y, Estrella MM, Kitahata MM, Wester CW, Bosch RJ, Crane H, Eron J, Gill MJ, Horberg MA, Justice AC, Klein M, Mayor AM, Moore RD, Palella FJ, Parikh CR, Silverberg MJ, Golub ET, Jacobson LP, Napravnik S, Lucas GM, North American ACCoR, Design of the International Epidemiologic Databases to Evaluate A. End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis. 2015: 941 [PMID: 25409471, https://doi.org/10.1093/cid/ciu919]
74. Husain NE, Ahmed MH, Almobarak AO, Noor SK, Elmadhoun WM, Awadalla H, Woodward CL, Mital D. HIV-Associated Nephropathy in Africa: Pathology, Clinical Presentation and Strategy for Prevention. J Clin Med Res. 2018: 1 [PMID: 29238427, https://doi.org/10.14740/jocmr3235w]
75. Wei J, Hou J, Su B, Jiang T, Guo C, Wang W, Zhang Y, Chang B, Wu H, Zhang T. The Prevalence of Frascati-Criteria-Based HIV-Associated Neurocognitive Disorder (HAND) in HIV-Infected Adults: A Systematic Review and Meta-Analysis. Front Neurol. 2020: 581346 [PMID: 33335509, https://doi.org/10.3389/fneur.2020.581346]
76. Ayele BA, Amogne W, Gemechu L. HIV-associated neurocognitive disorder and HIV-associated myelopathy in a patient with a preserved CD4, but high viral load-a rarely reported phenomenon: a case report and literature review. BMC Infect Dis. 2020: 574 [PMID: 32758161, https://doi.org/10.1186/s12879-020-05297-9]
77. Zenebe Y, Akele B, M WS, Necho M. A systematic review and meta-analysis of HIV associated neurocognitive disorders (HAND) among people with HIV in Ethiopia. AIDS Res Ther. 2021: 99 [PMID: 34924002, https://doi.org/10.1186/s12981-021-00424-1]
78. Mekuriaw B, Belayneh Z, Teshome W, Akalu Y. Prevalence and variability of HIV/AIDS-associated neurocognitive impairments in Africa: a systematic review and meta-analysis. BMC Public Health. 2023: 997 [PMID: 37254121, https://doi.org/10.1186/s12889-023-15935-x]
79. Belayneh Z, Mekuriaw B, Mehare T, Shumye S, Tsehay M. Magnitude and predictors of common mental disorder among people with HIV/AIDS in Ethiopia: a systematic review and meta-analysis. BMC Public Health. 2020: 689 [PMID: 32410600, https://doi.org/10.1186/s12889-020-08800-8]
80. Rafiei S, Raoofi S, Pashazadeh Kan F, Masoumi M, Doustmehraban M, Biparva AJ, Ashari A, Vali N, Khani S, Abdollahi B, Vaziri Shahrebabak ESV, Heydari M, Momeni Z, Kasaie ZA, Beliad M, Ghashghaee A. Global prevalence of suicide in patients living with HIV/AIDS: A systematic review and meta-analysis. J Affect Disord. 2023: 400 [PMID: 36455715, https://doi.org/10.1016/j.jad.2022.11.061]
81. Opoku Agyemang S, Ninonni J, Bennin L, Agyare E, Gyimah L, Senya K, Birikorang E, Quarshie EN, Baddoo NA, Addo SA, Obiri-Yeboah D. Prevalence and associations of depression, anxiety, and stress among people living with HIV: A hospital-based analytical cross-sectional study. Health Sci Rep. 2022: e754 [PMID: 35949667, https://doi.org/10.1002/hsr2.754]
82. Vondo N, Mabaso M, Ginyana T, Malope L, Moyo S, Zungu N, Shisana O. Determinants of psychological distress among individuals who are aware of their HIV serostatus in South Africa: findings from the 2017 national HIV prevalence, incidence, behavior, and communication survey. Front Public Health. 2024: 1387878 [PMID: 38846607, https://doi.org/10.3389/fpubh.2024.1387878]
83. Ashry M, Ziady H, Hameed M, Mohammed F. Health-related quality of life in healthy children and adolescents of HIV-infected parents in Alexandria, Egypt. J Egypt Public Health Assoc. 2017: 212 [PMID: 30612381, https://doi.org/10.21608/EPX.2018.22042]
84. Sunagawa SW, Bares SH, Scarsi KK, Podany A, Mykris T, Weinhold J, O'Neill J, Kubat M, Cramer D, Davis JM, Havens JP. Sustained HIV Viral Suppression 18 Months After the Last Dose of Long-acting Cabotegravir/Rilpivirine: A Case Report. Open Forum Infect Dis. 2025: ofaf399 [PMID: 40704172, https://doi.org/10.1093/ofid/ofaf399]
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Asem Mohsen, Mostafa Alfishawy